Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (351-360 of 755) with videos related to

Pageof 76
Sort By:
Arthritis Research & Therapy|August 25, 2022
Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumabAndrea Rubbert-Roth, Daniel E Furst, Stefano Fiore, et al.
The Journal of Rheumatology|March 23, 2002
Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenacDaniel E Furst, Karen S Kolba, Roy Fleischmann, et al.
Arthritis Care & Research|October 11, 2014
Two dosing regimens of certolizumab pegol in patients with active rheumatoid arthritisD E Furst, S A Shaikh, M Greenwald, et al.
Arthritis and Rheumatism|May 1, 1989
Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind studyD E Furst, P J Clements, S Hillis, et al.
Clinical Rheumatology|March 12, 2018
Ultrasound characterization of cutaneous ulcers in systemic sclerosisYossra A Suliman, Suzanne Kafaja, John Fitzgerald, et al.
Journal of Endocrinological Investigation|February 1, 1990
Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosisL De Keyser, D C Narhi, D E Furst, et al.
Annals of the Rheumatic Diseases|November 20, 2004
Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a sonN C Lambert, J M Pang, Z Yan, et al.
Arthritis Care & Research|August 5, 2015
Certolizumab Pegol Efficacy Across Methotrexate Regimens: A Pre-Specified Analysis of Two Phase III TrialsBernard Combe, Daniel E Furst, Edward C Keystone, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 20, 2015
Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial HypertensionMatthew R Lammi, Stephen C Mathai, Lesley Ann Saketkoo, et al.
Chest|February 1, 1994
Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysisD P Tashkin, P J Clements, R S Wright, et al.
Pageof 76

Showing results (351-360 of 755) with videos related to

Sort By:
Pageof 76
Arthritis Research & Therapy|August 25, 2022
Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumabAndrea Rubbert-Roth, Daniel E Furst, Stefano Fiore, et al.
The Journal of Rheumatology|March 23, 2002
Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenacDaniel E Furst, Karen S Kolba, Roy Fleischmann, et al.
Arthritis Care & Research|October 11, 2014
Two dosing regimens of certolizumab pegol in patients with active rheumatoid arthritisD E Furst, S A Shaikh, M Greenwald, et al.
Arthritis and Rheumatism|May 1, 1989
Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind studyD E Furst, P J Clements, S Hillis, et al.
Clinical Rheumatology|March 12, 2018
Ultrasound characterization of cutaneous ulcers in systemic sclerosisYossra A Suliman, Suzanne Kafaja, John Fitzgerald, et al.
Journal of Endocrinological Investigation|February 1, 1990
Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosisL De Keyser, D C Narhi, D E Furst, et al.
Annals of the Rheumatic Diseases|November 20, 2004
Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a sonN C Lambert, J M Pang, Z Yan, et al.
Arthritis Care & Research|August 5, 2015
Certolizumab Pegol Efficacy Across Methotrexate Regimens: A Pre-Specified Analysis of Two Phase III TrialsBernard Combe, Daniel E Furst, Edward C Keystone, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 20, 2015
Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial HypertensionMatthew R Lammi, Stephen C Mathai, Lesley Ann Saketkoo, et al.
Chest|February 1, 1994
Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysisD P Tashkin, P J Clements, R S Wright, et al.
Pageof 76